Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, USA.
J Transl Med. 2011 Jan 27;9 Suppl 1(Suppl 1):S6. doi: 10.1186/1479-5876-9-S1-S6.
To enter target cells HIV-1 uses CD4 and a coreceptor. In vivo the coreceptor function is provided either by CCR5 (for R5) or CXCR4 (for X4 HIV-1). Although both R5 and X4 HIV-1 variants are present in body fluids (semen, blood, cervicovaginal and rectal secretions), R5 HIV-1 appears to transmit infection and dominates early stages of HIV disease. Moreover, recent sequence analysis of virus in acute infection shows that, in the majority of cases of transmission, infection is initiated by a single virus. Therefore, the existence of a "gatekeeper" that selects R5 over X4 HIV-1 and that operates among R5 HIV-1 variants has been suggested. In the present review we consider various routes of HIV-transmission and discuss potential gatekeeping mechanisms associated with each of these routes. Although many mechanisms have been identified none of them explains the almost perfect selection of R5 over X4 in HIV-1 transmission. We suggest that instead of one strong gatekeeper there are multiple functional gatekeepers and that their superimposition is sufficient to protect against X4 HIV-1 infection and potentially select among R5 HIV-1 variants. In conclusion, we propose that the principle of multiple barriers is more general and not restricted to protection against X4 HIV-1 but rather can be applied to other phenomena when one factor has a selective advantage over the other(s). In the case of gatekeepers for HIV-1 transmission, the task is to identify them and to decipher their molecular mechanisms. Knowledge of the gatekeepers' localization and function may enable us to enhance existing barriers against R5 transmission and to erect the new ones against all HIV-1 variants.
HIV-1 进入靶细胞需要 CD4 和辅助受体。在体内,辅助受体的功能由 CCR5(用于 R5)或 CXCR4(用于 X4 HIV-1)提供。虽然 R5 和 X4 HIV-1 变体都存在于体液(精液、血液、宫颈阴道和直肠分泌物)中,但 R5 HIV-1 似乎更容易传播感染,并在 HIV 疾病的早期阶段占据主导地位。此外,最近对急性感染病毒的序列分析表明,在大多数传播情况下,感染是由单一病毒引发的。因此,有人提出了一种“守门员”的存在,它选择 R5 而不是 X4 HIV-1,并且在 R5 HIV-1 变体中起作用。在本综述中,我们考虑了 HIV 传播的各种途径,并讨论了与这些途径相关的潜在门控机制。尽管已经确定了许多机制,但没有一种机制能够解释 R5 在 HIV-1 传播中对 X4 的近乎完美选择。我们认为,不是一个强大的守门员,而是有多个功能守门员,它们的叠加足以防止 X4 HIV-1 感染,并可能在 R5 HIV-1 变体中进行选择。总之,我们提出,多重障碍的原则更为普遍,不仅限于防止 X4 HIV-1,而是可以应用于其他因素具有选择性优势的现象。在 HIV-1 传播的守门员的情况下,任务是识别它们并破译它们的分子机制。了解守门员的定位和功能,可能使我们能够增强现有的 R5 传播屏障,并建立新的屏障,以抵御所有 HIV-1 变体。